Working… Menu

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04414631
Recruitment Status : Recruiting
First Posted : June 4, 2020
Last Update Posted : February 17, 2021
Pharming Technologies B.V.
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland